2015
DOI: 10.1007/s10517-015-2782-3
|View full text |Cite
|
Sign up to set email alerts
|

Specific Anti-IIa Activity is a Key Indicator of Safety and Efficacy in Validation of Biosimilarity of Unfractioned Heparin Preparations

Abstract: We compared anti-IIa activity of a heparin analogue and a reference product was carried out to confirm their biosimilarity. The experiment was based on the method of estimation of anti-IIa activity of a commercial sodium heparin preparation according to United States Pharmacopoeia. High similarity of the two medicinal heparin preparations by this parameter is shown. The method is recommended for the use in comparability studies.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2018
2018
2018
2018

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 3 publications
0
1
0
Order By: Relevance
“…Anti-IIa assays are then the right methods for measuring the anti-thrombin activity of large heparin molecules [10]. The Heparin Anti-IIa method is a two-stage method based on the inhibition of a constant amount of Thrombin (IIa), by the tested heparin in presence of exogenous antithrombin, then hydrolysis of a Thrombin specific chromogenic substrate, by Thrombin in excess.…”
Section: Introductionmentioning
confidence: 99%
“…Anti-IIa assays are then the right methods for measuring the anti-thrombin activity of large heparin molecules [10]. The Heparin Anti-IIa method is a two-stage method based on the inhibition of a constant amount of Thrombin (IIa), by the tested heparin in presence of exogenous antithrombin, then hydrolysis of a Thrombin specific chromogenic substrate, by Thrombin in excess.…”
Section: Introductionmentioning
confidence: 99%